×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Poultry Vaccines Market

ID: MRFR/Pharma/48784-HCR
200 Pages
Rahul Gotadki
February 2026

China Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Poultry Vaccines Market Infographic
Purchase Options

China Poultry Vaccines Market Summary

As per Market Research Future analysis, the China Poultry Vaccines Market size was estimated at 123.0 USD Million in 2024. The Poultry Vaccines market is projected to grow from 131.14 USD Million in 2025 to 249.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China poultry vaccines market is experiencing robust growth driven by technological advancements and increasing demand for poultry production.

  • Technological advancements in vaccine development are enhancing efficacy and safety, thereby boosting market growth.
  • Government initiatives and regulations are fostering a supportive environment for vaccination programs across the poultry sector.
  • Rising awareness of animal health among consumers is driving demand for high-quality poultry products.
  • The increasing poultry production demand and emerging infectious diseases are key drivers propelling the market forward.

Market Size & Forecast

2024 Market Size 123.0 (USD Million)
2035 Market Size 249.0 (USD Million)
CAGR (2025 - 2035) 6.62%

Major Players

Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Vetoquinol (FR), Huvepharma (BG), Phibro Animal Health (US), IDT Biologika (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Poultry Vaccines Market Trends

The China Poultry Vaccines Market in China is currently experiencing notable growth, driven by increasing demand for poultry products and heightened awareness regarding animal health. The government has implemented various initiatives aimed at enhancing biosecurity measures and promoting vaccination programs among poultry farmers. This focus on disease prevention is crucial, as outbreaks of avian diseases can have devastating effects on both the economy and food supply. Furthermore, advancements in vaccine technology are contributing to the development of more effective and targeted vaccines, which may improve overall poultry health and productivity. In addition, the rising trend of industrialization in poultry farming is influencing the poultry vaccines market. As farms become larger and more integrated, the need for comprehensive vaccination strategies becomes more pronounced. This shift towards larger operations may lead to increased investments in veterinary services and vaccine procurement. Moreover, the growing emphasis on food safety and quality assurance is likely to drive further adoption of vaccination practices among poultry producers. Overall, the The market appears poised for continued expansion., reflecting the evolving landscape of animal husbandry in China.

Technological Advancements in Vaccines

Recent innovations in vaccine development are enhancing the efficacy and safety of poultry vaccines. New formulations and delivery methods are being explored, which may lead to improved immune responses in poultry. This trend suggests a shift towards more sophisticated vaccination strategies that could better address emerging diseases.

Government Initiatives and Regulations

The Chinese government is actively promoting vaccination programs to combat poultry diseases. Regulatory frameworks are being established to ensure the quality and safety of vaccines. These initiatives may encourage poultry farmers to adopt vaccination practices, thereby potentially increasing market demand.

Rising Awareness of Animal Health

There is a growing recognition among poultry producers regarding the importance of vaccination in maintaining flock health. This heightened awareness may lead to increased investment in vaccination programs, as farmers seek to enhance productivity and reduce losses associated with disease outbreaks.

China Poultry Vaccines Market Drivers

Emerging Infectious Diseases

The emergence of infectious diseases poses a significant challenge to poultry farming in China, driving the poultry vaccines market. Recent outbreaks of avian influenza and Newcastle disease have highlighted the vulnerability of poultry to viral infections. In response, the industry is increasingly investing in vaccine development to mitigate these risks. The poultry vaccines market is projected to grow as farmers prioritize vaccination to protect their flocks from these diseases. The Chinese government has also recognized the importance of vaccination in disease control, potentially leading to increased funding and support for vaccine research and distribution. This focus on disease prevention is likely to enhance the overall health of poultry populations, thereby supporting market growth.

Increasing Poultry Production Demand

The growing demand for poultry products in China is a primary driver for the poultry vaccines market. As the population continues to expand, the need for protein-rich food sources, particularly chicken, is on the rise. In 2025, poultry production in China is projected to reach approximately 20 million metric tons, necessitating enhanced biosecurity measures. Vaccination plays a crucial role in maintaining flock health and productivity, thereby supporting the increasing output. The poultry vaccines market is expected to benefit from this trend, as farmers seek effective solutions to prevent disease outbreaks that could disrupt production. Consequently, the demand for innovative vaccines is likely to surge, reflecting the industry's response to the heightened need for poultry products.

Regulatory Support for Vaccination Programs

Regulatory frameworks in China are increasingly supportive of vaccination programs, which is a key driver for the poultry vaccines market. The government has implemented policies aimed at promoting animal health and welfare, including vaccination initiatives. These regulations encourage poultry farmers to adopt vaccination as a standard practice, thereby enhancing flock immunity and reducing disease prevalence. The poultry vaccines market is likely to benefit from this regulatory support, as it creates a conducive environment for vaccine adoption. Furthermore, compliance with these regulations may lead to increased funding for vaccine research and development, further stimulating market growth.

Consumer Preferences for Safe Poultry Products

Consumer preferences in China are shifting towards safe and healthy poultry products, which is influencing the poultry vaccines market. As awareness of food safety issues rises, consumers are demanding assurance that poultry products are free from diseases. This trend is prompting producers to invest in vaccination programs to ensure the health of their flocks. The poultry vaccines market is expected to grow as farmers recognize the importance of vaccination in meeting consumer expectations. Additionally, the emphasis on food safety may lead to increased collaboration between producers and vaccine manufacturers, fostering innovation and improving vaccine availability in the market.

Technological Innovations in Vaccine Development

Technological advancements in vaccine development are transforming the poultry vaccines market. Innovations such as recombinant vaccines and mRNA technology are being explored to enhance vaccine efficacy and safety. These developments may lead to more effective immunization strategies, reducing the incidence of diseases in poultry. In China, the adoption of these technologies is expected to increase as producers seek to improve flock health and productivity. The poultry vaccines market could see a shift towards more sophisticated vaccine formulations that offer broader protection against multiple pathogens. This trend may also encourage collaboration between research institutions and vaccine manufacturers, fostering a more dynamic market environment.

Market Segment Insights

By Type: Live Attenuated Vaccines (Largest) vs. Inactivated Vaccines (Fastest-Growing)

The China poultry vaccines market showcases a diverse range of vaccine types, with live attenuated vaccines holding the largest market share. These vaccines are widely preferred for their effectiveness in stimulating immunity in poultry. In contrast, inactivated vaccines are also significant but are growing rapidly due to increasing awareness about biosecurity and the need for effective disease management in poultry farming. Growth trends within this segment are primarily driven by the rising demand for higher poultry production and the necessity to prevent disease outbreaks. The shift towards more sophisticated farming practices and enhanced veterinary care further fuels this demand. Additionally, the emergence of subunit and DNA vaccines presents new opportunities as they offer targeted protection, aligning well with trends favoring innovation in livestock health management.

Live Attenuated Vaccines (Dominant) vs. Inactivated Vaccines (Emerging)

Live attenuated vaccines dominate the China poultry vaccines market due to their proven efficacy and ability to induce long-lasting immunity. They are often preferred for their cost-effectiveness in large-scale poultry operations. Conversely, inactivated vaccines represent an emerging segment fueled by advances in vaccine technology and a growing emphasis on biosecurity. These vaccines offer safer alternatives, particularly in sensitive populations, and their development is gaining momentum. Overall, while live attenuated vaccines remain the go-to option, inactivated vaccines are increasingly recognized for their potential to complement existing solutions and address specific health challenges in poultry farming.

By Species: Broilers (Largest) vs. Layers (Fastest-Growing)

In the China poultry vaccines market, the distribution of market share among the different species segments reveals that broilers hold the largest share, driven by their significant presence in poultry meat production. Layers also contribute a substantial portion to the market, catering primarily to egg production. The presence of turkeys and other poultry species is comparatively smaller, indicating a focused dominance of broilers and layers in vaccine uptake. The growth trends in this segment reveal a notable increase in the demand for vaccines among layers, positioning them as the fastest-growing segment. This can be attributed to rising consumer demand for high-quality eggs and the need for improved biosecurity measures in poultry farming. Additionally, the increasing awareness of poultry diseases is fostering a more proactive approach to vaccination in layers, further accelerating growth in this segment.

Broilers: Largest vs. Layers: Fastest-Growing

Broilers represent the largest segment in the market, primarily due to their pivotal role in fulfilling the rising meat consumption in China. They benefit from economies of scale and established vaccination protocols, ensuring robust health management. On the other hand, layers are emerging rapidly, driven by the growth in egg production and evolving consumer preferences towards quality and safety in food products. The demand for layer vaccinations is propelled by market pressures for higher productivity and adherence to health regulations, thus making this segment a strategic focus for vaccine manufacturers aiming to innovate and enhance product offerings.

By Administration Route: Intramuscular (Largest) vs. Oral (Fastest-Growing)

In the China poultry vaccines market, Intramuscular administration currently holds the largest market share among administration routes, being widely preferred by poultry farmers for its effectiveness and reliability in delivering vaccines. Conversely, Oral administration is gaining traction due to its ease of use and non-invasive nature, appealing particularly to smaller farms looking for efficient vaccination methods without the need for specialized training or equipment. Growth trends indicate that while Intramuscular remains dominant, Oral administration is quickly becoming the fastest-growing segment as more poultry producers recognize its benefits. The push for improved animal welfare and productivity is driving innovation in vaccine delivery methods, with Oral vaccines promising reduced stress on birds and enhanced uptake rates, further contributing to its rising popularity in the market.

Intramuscular (Dominant) vs. Oral (Emerging)

Intramuscular administration is characterized by its direct injection into the muscle, providing a quick immune response and ensuring that vaccines are effectively absorbed. This method is favored for its proven efficacy, especially in mass vaccination campaigns for poultry health management. In contrast, Oral administration offers an emerging alternative that simplifies the vaccination process, allowing for easy incorporation into feed or water. This method not only reduces handling stress on the animals but also enhances user convenience. As the demand for cost-effective and efficient vaccination methods rises, Oral administration is poised to capture a larger market share, appealing to both large commercial hatcheries and small family-owned farms seeking accessible solutions.

By Disease Targeted: Newcastle Disease (Largest) vs. Avian Influenza (Fastest-Growing)

In the China poultry vaccines market, Newcastle Disease dominates the vaccine segment due to its widespread prevalence and the high mortality rates in infected flocks. Infectious Bursal Disease also holds a significant market share, while Avian Influenza is rapidly gaining traction, driven by recent outbreaks that have heightened biosecurity measures across poultry farms. Marek's Disease, while important, occupies a smaller share in comparison, reflecting less urgency among poultry producers. Growth trends in this segment are primarily influenced by regulatory changes and an increased focus on animal health. The rising incidence of Avian Influenza is pushing producers to adopt newer vaccine technologies, making it the fastest-growing segment. Newcastle Disease, however, remains a staple in vaccination protocols, driving consistent demand. Investment in research and development is expected to propel growth further, particularly for emerging vaccines with broader efficacy against various strains.

Newcastle Disease (Dominant) vs. Marek's Disease (Emerging)

Newcastle Disease represents the dominant force in the China poultry vaccines market, benefiting from its historic presence and strong awareness among poultry producers. The vaccines targeting this disease are well-established, with extensive usage proven to be effective in mitigating outbreaks. In contrast, Marek's Disease is emerging as a growing concern due to the increasing prevalence among vaccinated flocks, necessitating innovative vaccine solutions. As the poultry industry evolves with technological advancements, vaccines for Marek's Disease are witnessing advancements in efficacy and formulation, positioning them as vital for future growth. Enhanced focus on biosecurity and vaccination strategies offers a promising market landscape for both these segments.

Get more detailed insights about China Poultry Vaccines Market

Key Players and Competitive Insights

The poultry vaccines market in China is characterized by a dynamic competitive landscape, driven by increasing demand for poultry products and heightened awareness of animal health. Key players such as Zoetis (US), Merck Animal Health (US), and Boehringer Ingelheim (DE) are strategically positioned to leverage innovation and regional expansion. These companies focus on developing advanced vaccine formulations and enhancing their distribution networks, which collectively shapes a competitive environment that is both concentrated and moderately fragmented. The emphasis on research and development, alongside strategic partnerships, appears to be a common thread among these firms, fostering a robust ecosystem for growth.In terms of business tactics, localizing manufacturing and optimizing supply chains are pivotal strategies employed by leading companies. The market structure reflects a blend of concentrated and fragmented elements, with a few dominant players holding substantial market shares while numerous smaller firms cater to niche segments. This duality allows for competitive pricing and innovation, as larger companies invest heavily in R&D while smaller entities often focus on specialized products or services.

In October Zoetis (US) announced the launch of a new vaccine targeting avian influenza, which is expected to enhance biosecurity measures in poultry farms across China. This strategic move not only reinforces Zoetis's commitment to innovation but also addresses a critical health concern in the poultry industry, potentially increasing their market share significantly. The introduction of this vaccine aligns with the growing demand for effective disease management solutions in the region.

In September Merck Animal Health (US) expanded its partnership with local distributors to enhance its market penetration in China. This strategic alliance is likely to improve the accessibility of their vaccine products, thereby increasing their competitive edge. By leveraging local expertise and distribution networks, Merck aims to respond more effectively to regional market needs, which could lead to a stronger foothold in the rapidly evolving poultry vaccines market.

In August Boehringer Ingelheim (DE) launched a digital platform aimed at providing farmers with real-time data on vaccine efficacy and poultry health management. This initiative reflects a broader trend towards digitalization in the industry, enabling farmers to make informed decisions based on data analytics. The integration of technology into vaccine management systems may enhance customer loyalty and operational efficiency, positioning Boehringer Ingelheim as a leader in innovative solutions.

As of November current trends in the poultry vaccines market indicate a shift towards digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of developing robust, sustainable practices that not only meet market demands but also enhance overall operational resilience.

Key Companies in the China Poultry Vaccines Market include

Industry Developments

In recent developments within the China Poultry Vaccines Market, companies like Ringpu BioTechnologies and Merial have been enhancing their vaccination strategies, focusing on innovative technologies to combat avian diseases. In September 2023, Hester Biosciences Limited announced its plans to expand its vaccine production capabilities in China, reflecting a growing demand for poultry vaccines due to increased poultry farming. Concurrently, Zoetis and Elanco Animal Health have reported steady growth in their market valuations attributed to rising awareness regarding poultry health.

Notably, Merck Animal Health has intensified its R&D investments in the region, targeting emerging viral threats that affect poultry. In terms of mergers and acquisitions, Yunnan Huize Animal Health made headlines in August 2023 by acquiring a local vaccine producer, aiming to strengthen its market presence. The Chinese government’s initiatives to bolster its animal health sector over the past few years have fostered favorable conditions for companies like Virbac and CEVA Santé Animale, enabling them to broaden their market reach.

Overall, the landscape of the China Poultry Vaccines Market is increasingly dynamic, driven by advancements in technology, strategic partnerships, and growing regulatory support.

Future Outlook

China Poultry Vaccines Market Future Outlook

The Poultry Vaccines Market in China is projected to grow at a 6.62% CAGR from 2025 to 2035, driven by increasing poultry production and disease management needs.

New opportunities lie in:

  • Development of advanced adjuvants for enhanced vaccine efficacy.
  • Expansion of digital platforms for vaccine distribution and tracking.
  • Investment in R&D for novel vaccines targeting emerging poultry diseases.

By 2035, the poultry vaccines market is expected to achieve substantial growth and innovation.

Market Segmentation

China Poultry Vaccines Market Type Outlook

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines

China Poultry Vaccines Market Species Outlook

  • Broilers
  • Layers
  • Turkeys
  • Others

China Poultry Vaccines Market Disease Targeted Outlook

  • Newcastle Disease
  • Infectious Bursal Disease
  • Avian Influenza
  • Marek's Disease

China Poultry Vaccines Market Administration Route Outlook

  • Intramuscular
  • Subcutaneous
  • Oral
  • Inhalation

Report Scope

MARKET SIZE 2024 123.0(USD Million)
MARKET SIZE 2025 131.14(USD Million)
MARKET SIZE 2035 249.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.62% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Vetoquinol (FR), Huvepharma (BG), Phibro Animal Health (US), IDT Biologika (DE)
Segments Covered Type, Species, Administration Route, Disease Targeted
Key Market Opportunities Emerging technologies in poultry vaccines enhance disease prevention and improve flock health management.
Key Market Dynamics Rising demand for poultry vaccines driven by regulatory changes and increasing awareness of animal health in China.
Countries Covered China
Leave a Comment

FAQs

What is the expected market size of the China Poultry Vaccines Market in 2024?

The China Poultry Vaccines Market is expected to be valued at 423.0 million USD in 2024.

What is the projected market size of the China Poultry Vaccines Market by 2035?

By 2035, the market is projected to reach a value of 759.0 million USD.

What is the expected compound annual growth rate (CAGR) for the China Poultry Vaccines Market from 2025 to 2035?

The expected CAGR for the China Poultry Vaccines Market from 2025 to 2035 is 5.459%.

Which type of vaccines dominate the China Poultry Vaccines Market in 2024?

In 2024, Live Attenuated Vaccines dominate the market, valued at 150.0 million USD.

What is the expected value of Inactivated Vaccines in 2035?

Inactivated Vaccines are expected to be valued at 210.0 million USD by the year 2035.

Who are some of the major players in the China Poultry Vaccines Market?

Major players in the market include Ringpu BioTechnologies, Merial, and Zoetis among others.

What value are DNA Vaccines expected to reach by 2035 in the China Poultry Vaccines Market?

By 2035, DNA Vaccines are expected to reach a value of 144.0 million USD.

Which segment is seeing considerable growth within the China Poultry Vaccines Market?

The Subunit Vaccines segment is expected to grow to a value of 135.0 million USD by 2035.

What are the key growth drivers for the China Poultry Vaccines Market?

The growth of this market is driven by increasing poultry production and the need for disease control.

How significant is the impact of global scenarios on the China Poultry Vaccines Market?

Global scenarios significantly influence supply chains and vaccine availability in the China Poultry Vaccines Market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions